DNAPrint Genomics DNAG · USD

Market value

$365

Last close × shares

Volume

61.2k

Shares, 9 Nov 2026

Its shares trade under the ticker DNAG. It has been listed since 23 February 2001. In the fiscal year to 31 December 2006, it reported revenue of $2.4m and a net loss of $12.3m. At that date it held total assets of $10.3m and shareholders' equity of −$3.7m.

DNAPrint Genomics, Inc. engages in the research and development of genomics-based products and services for biomedical and forensics. The company is headquartered in Sarasota, Florida. The company went IPO on 2001-02-23. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The firm generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The firm provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.

Figures and description from our data supplier, not checked against the company's own report.

More about DNAPrint Genomics →

We have not reported on DNAPrint Genomics yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.